European Respiratory Journal, European Respiratory Review, ERJ Open Research, Breathe, the ERS Monograph and ERS Handbooks, and European Lung White Book
ERR: A synthesis of 48 air-pollution GxE studies found 89 significant SNPs showed GST/TLR variants consistently amplify pollution-related lung function decline and airway inflammation, calling for multi-ethnic studies and multi-omics for precision care. https://t.co/1UJUVMsTaA
ERJ Open Research: Biological therapies affect different eosinophil subpopulations (inflammatory and resident eosinophils). Mepolizumab reduced iEos markedly while dupilumab and omalizumab did not change subpopulations compared with naive patients. https://t.co/ZJrmdxZNDi
Eur Respir Rev: COPD maintenance management trials measure heterogeneous outcomes and often overlook those that matter most to patients. This review of 240 RCTs underscores the urgent need for a globally representative, patient-centred core outcome set. https://t.co/aGmImmeTu0
La hiperoxia no es inocua, ya que puede contribuir al daño pulmonar durante la ventilación mecánica.
Los ensayos clínicos apoyan una estrategia conservadora de oxigenoterapia, recordando que en pacientes críticos, más oxígeno no es sinónimo de mejor atención.
#ERSCongress2026: Top picks from ERS President Elect, Dr Marc Miravitlles
💡 Which hot topics does Marc anticipate most?
📅 Which sessions is he looking forward to?
🩵 How significant is this year's theme?
Read insight from Marc online: https://t.co/I4YlZqZ7Tw
ERJ Open Research: Most clinically stable children with PCD had visible ventilation abnormalities when assessed with 129Xe MRI. 129Xe-derived VDP was abnormal in 75% of children who had normal FEV1. https://t.co/DfMLsrhZQz
ERR: In paediatric macrolide-resistant M. pneumoniae pneumonia systemic corticosteroids may be considered a timely, risk-stratified adjunct guided by clinical, radiologic and biomarker assessment, rather than a last-resort or fixed-threshold intervention. https://t.co/5yE7LU1Wmh
This study on patient perspectives on ultrasound-guided thoracic procedures highlighted how patients value the time and opportunity to ask questions prior to a procedure, private and dedicated procedural space, and good bedside manners from clinicians https://t.co/O0F5WUZ2o2
La EA #EPOC requiere intervenciones multidisciplinarias para alcanzar el mayor beneficio para el paciente.
Debemos estrechar la brecha entre evidencia y práctica clínica.
Dejo un tip como neumólogo...
No uses broncodilatadores si no tienes función pulmonar registrada.
Pre-clinical studies show hyperoxia amplifies lung injury in mechanical ventilation. While clinical trials suggest conservative oxygen therapy is noninferior to liberal therapy, mechanistic evidence supports limiting hyperoxia exposure in critical illness. https://t.co/fl3z2xA2Oe
AECOPD care bundles bridge the evidence–practice gap by delivering high-impact, multidisciplinary interventions across hospitalisation and discharge transitions. Benefit depends on context-sensitive design, implementation and integration of digital tools. https://t.co/sdnl31ZVR5
European Respiratory Review: HFNC could be considered as an initial treatment modality in paediatric patients with bronchiolitis, especially in patients requiring escalation of treatment from LFNC https://t.co/Lo0wdWm3zu
European Respiratory Review: Air pollution disrupts airway epithelial barriers via ROS, inflammation and ciliary dysfunction in COPD. Targeting oxidative stress and barrier repair may reduce exacerbations, especially in high-pollution areas. https://t.co/uXNvwvmsoe
European Respiratory Review: Primary ciliary dyskinesia is entering a transformative phase of innovative therapies, requiring robust preclinical models to study mechanisms and evaluate efficacy, toxicity and cell–specific activity. https://t.co/cGKdpVEdBp
This scoping review of applied in vitro PCD models revealed a lack of standardised characterisation and outcomes reporting. Consensus is needed on the minimum requirements for model characterisation, which will facilitate translational applications. https://t.co/cGhI3KzwED
📹 Guidelines in Focus: Prof. Saskia Bos interviews co-chairs Prof. Jourke Anema and Prof. Peter Vilmann on ERS/ESGE/ESTS guidelines for endosonography in lung cancer staging.
Watch now 👇
https://t.co/3ywGaSdEoU
European Respiratory Review: The heterogeneity of treatment effect observed in trials of systemic corticosteroids in sCAP is likely due to a multitude of immune- and nonimmune-mediated mechanisms which vary between underexplored disease endotypes. https://t.co/wyIXu2xvNe